Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Movement Disorders Channel:
Parkinson's Disease

Welcome to The Parkinson’s Disease Channel

VJNeurology brings you the latest updates in Parkinson’s disease directly from world-leading experts. The Parkinson’s Disease Channel brings you video interviews from international conferences.

Discover key developments in this space, including updates in disease biology, novel treatment strategies, and ongoing clinical trials.

Novel synuclein mutations and their potential impact in Parkinson’s disease 2:46
Novel synuclein mutations and their potential impact in Parkinson’s disease
Tiago Outeiro • 19 Mar 2026
The limitations of currently approved treatments for Parkinson’s disease 1:15
The limitations of currently approved treatments for Parkinson’s disease
Fabrizio Stocchi • 20 Mar 2026
An overview of current trials investigating novel approaches for the treatment of PD 2:37
An overview of current trials investigating novel approaches for the treatment of PD
Fabrizio Stocchi • 20 Mar 2026
Advice for referring patients with Parkinson’s disease for advanced therapies 1:38
Advice for referring patients with Parkinson’s disease for advanced therapies
Fabrizio Stocchi • 20 Mar 2026
Factors contributing to neurodegeneration in PD and strategies being explored for prevention 2:33
Factors contributing to neurodegeneration in PD and strategies being explored for prevention
Fabrizio Stocchi • 20 Mar 2026
An algorithm to guide clinicians on cognitive evaluation in Parkinson’s disease 4:01
An algorithm to guide clinicians on cognitive evaluation in Parkinson’s disease
Dana Pourzinal • 20 Oct 2025
Recommendations for treating and managing cognitive disorders in Parkinson’s disease 4:34
Recommendations for treating and managing cognitive disorders in Parkinson’s disease
Dana Pourzinal • 20 Oct 2025
The prevalence of cognitive impairment in Parkinson’s disease and the need to standardize assessment 3:09
The prevalence of cognitive impairment in Parkinson’s disease and the need to standardize assessment
Dana Pourzinal • 20 Oct 2025
Basic science of movement disorders: recent updates in the field 3:17
Basic science of movement disorders: recent updates in the field
Tiago Outeiro • 15 Oct 2025
The alpha-synuclein seed amplification assay and the need to consider Parkinson’s beyond movement 2:08
The alpha-synuclein seed amplification assay and the need to consider Parkinson’s beyond movement
Tiago Outeiro • 15 Oct 2025
Key emerging data and evolving concepts in prion-like mechanisms of proteinopathies 2:42
Key emerging data and evolving concepts in prion-like mechanisms of proteinopathies
Tiago Outeiro • 15 Oct 2025
Two novel alpha-synuclein missense variants identified in patients with Parkinson’s disease 2:09
Two novel alpha-synuclein missense variants identified in patients with Parkinson’s disease
Tiago Outeiro • 15 Oct 2025
Incorporating biomarker testing into the diagnostic workup for patients with overlapping features 2:53
Incorporating biomarker testing into the diagnostic workup for patients with overlapping features
Anastasia Bougea • 16 Jun 2025
Monitoring patients with idiopathic REM sleep behavior disorder for neurodegenerative diseases 2:10
Monitoring patients with idiopathic REM sleep behavior disorder for neurodegenerative diseases
Gerard Mayà Casalprim • 22 Jun 2025
The BouNDless study: 24-hour subcutaneous levodopa/carbidopa infusion on motor symptom control in PD 2:40
The BouNDless study: 24-hour subcutaneous levodopa/carbidopa infusion on motor symptom control in PD
Joaquim Ferreira • 23 Jun 2025
The OASIS trial: the effects of opicapone on sleep disturbances in Parkinson’s disease 1:57
The OASIS trial: the effects of opicapone on sleep disturbances in Parkinson’s disease
Joaquim Ferreira • 23 Jun 2025
The content of VJNeurology is intended for healthcare professionals